How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation-Reference-Cited by-同舟云学术

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation

Published:2015-12-11 Issue:3 Volume:95 Page:437-449
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Schaefer Jordan K.,McBane Robert D.,Wysokinski Waldemar E.

Funder

review article

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2566-x.pdf

Reference69 articles.

1. Press Announcements > FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm230241.htm . Accessed July 8, 2014.

2. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151

3. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891

4. Granger CB, Alexander JH, McMurray JJV et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981–992

5. Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of DOACs in frail elderly patients in light of class genericization;International Journal of Cardiology;2024-09

2. Comparison between non-vitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis;The Egyptian Heart Journal;2024-08-09

3. Flapless Dental Implant Surgery in Bleeding Disorders;International Journal of Translational Medicine;2024-06-11

4. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24

5. Back to the Future: Observational Studies and Anticoagulant Selection for Nonvalvular Atrial Fibrillation;Stroke;2024-05